天成自控(603085.SH):收到客户項目定點通知
格隆匯3月27日丨天成自控(603085.SH)公佈,公司於近日收到某知名合資汽車企業(限於保密協議,無法披露其名稱,以下簡稱“客户”)乘用車座椅核心零部件項目的定點通知,公司被確定為該客户某乘用車座椅核心零部件的定點供應商。根據客户規劃,項目預計2025年12月開始量產,預計項目生命週期內配套乘用車總量為43.35萬輛。
本次獲得合資汽車企業客户乘用車座椅核心零部件的定點通知標誌着客户對公司持續創新能力、研發能力、產品質量及全產業鏈配套能力的認可,助力座椅核心零部件市場開拓。此次合作是公司在乘用車市場不斷拓展和深化的表現,有利於鞏固與提升公司在乘用車領域的影響力,對公司穩健持續發展具有重要意義。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.